Search results
Author(s):
Ken Okumura
Added:
3 years ago
Dr Ken Okumura (Saiseikai Kumamoto Hospital, Kumamoto, JP) discusses the rationale and results behind ELDERCARE-AF, which investigates low dose Edoxaban for elderly Japanese AF patients ineligible for standard anticoagulant therapy.
Questions:
1. What is the rationale for this study?
2. What were the objectives of this study, and its design?
3. What patients were included in the study?
4. What…
View more
PIELD Study
Author(s):
Ganapathi Palaniappan
,
Rhuban M Sundran
,
Afif Ashari
,
et al
Added:
1 year ago
Article
Author(s):
Linda Joosten
Added:
7 months ago
ESC 2023 — Dr Linda Joosten (Julius Center for Health Sciences and Primary Care, NL) joins us to discuss the findings of the FRAIL-AF trial.
FRAIL-AF is a multicentre, open-label randomised controlled clinical trial which studied frail elderly patients who receive vitamin K antagonist (VKA) treatment for atrial fibrillation (AF). Current clinical guidelines recommend non-vitamin K antagonists …
View more
John McNeill
Job title: Professor and head of School of Public Health and Preventive Medicine
Author
Matthew Dixon
Author
Pasquale Perrone-Filardi
Job title: Cardiologist
Author
Ken Okumura
Author
Michael Fu
Job title: Professor, Principal Investigator, Senior Consultant Physician/Cardiologist
Author
Prakash Deedwania
Job title: Professor of Medicine
Author
Author(s):
Ankur Kalra
,
Sukhjinder Nijjer
Added:
4 months ago
In this week's Parallax, Dr Ankur Kalra welcomes back Dr Sukhjinder Nijjer for their much-anticipated annual review of advancements in cardiovascular medicine that defined the year 2023.Dr Nijjer, a Consultant Cardiologist in the UK, serves as the President of the Royal Society of Medicine and is an Honorary Senior Clinical Lecturer at Imperial College London.Drs Kalra and Nijjer share their…
View more